<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04320836</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00243203</org_study_id>
    <nct_id>NCT04320836</nct_id>
  </id_info>
  <brief_title>Non-organic Signs to Predict Outcomes for Neck Pain</brief_title>
  <official_title>Prospective Study to Determine Evaluate the Validity and Predictive Ability of Physical Exam Signs for Cervical Radiculopathy to Predict Epidural Steroid Injection (ESI) Treatment Outcomes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington DC VA Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul National University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neck pain is the 4th leading cause of disability in the world, with approximately 50% being&#xD;
      neuropathic in nature. Epidural steroid injections (ESI) are one of the most commonly used&#xD;
      treatments for cervical radiculopathy. Physical exam signs, including non-organic signs, have&#xD;
      been shown to predict outcomes for low back pain treatments, but have yet to be adequately&#xD;
      studied for neck pain.&#xD;
&#xD;
      In this prospective, observational study, 72 patients with cervical radiculopathy undergoing&#xD;
      an initial ESI for this pain episode will undergo a comprehensive history and physical&#xD;
      examination that includes the presence of Spurling test, midline and paraspinal tenderness, 9&#xD;
      non-organic tests in 5 categories, and 3 questionnaires to assess depression, anxiety, sleep,&#xD;
      and somatization. The investigators will also evaluate patients' MRI results to determine&#xD;
      patients' precise pathology. Patients will then receive interlaminar cervical ESI. The&#xD;
      primary outcome measure will be the difference in the proportion of people with a positive&#xD;
      categorical outcome, defined as a &gt;/= 2-point decrease in arm pain 4 weeks post-procedure&#xD;
      coupled with a score &gt;/= 5 on a 7-point patient global impression of change (PGIC) scale 4&#xD;
      weeks post-treatment, indicating subjective improvement.&#xD;
&#xD;
      The main objectives of this study are to:&#xD;
&#xD;
        1. Determine the ability of physical exam, including non-organic signs, to predict ESI&#xD;
           outcomes in individuals with cervical radicular pain.&#xD;
&#xD;
        2. Determine the prevalence of different non-organic signs, and the association with other&#xD;
           factors that may be associated with non-organic illness such as psychopathology and&#xD;
           multiple unrelated pain conditions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Seventy-two patients with cervical radiculopathy undergoing an initial ESI for this pain&#xD;
      episode will undergo a comprehensive history and physical examination that includes the&#xD;
      presence of Spurling test, midline and paraspinal tenderness, 9 non-organic tests in 5&#xD;
      categories, and 3 questionnaires to assess depression, anxiety, sleep, and somatization.&#xD;
&#xD;
      Non-organic signs that the investigators will evaluate are:&#xD;
&#xD;
        1. Tenderness&#xD;
&#xD;
             1. Superficial&#xD;
&#xD;
             2. Non-anatomical (e.g. cervical radicular pain causing tenderness in the arm or&#xD;
                mid-back)&#xD;
&#xD;
        2. Sham stimulation&#xD;
&#xD;
             1. Downward pressure on head elicits neck pain&#xD;
&#xD;
             2. With hands clasped behind neck, passive rotation of shoulders elicits neck pain&#xD;
&#xD;
        3. Distraction&#xD;
&#xD;
           a. Inability to rotate head &gt; 45 degrees during overt range-of-motion testing, but&#xD;
           significantly greater range of motion when patient is lying prone and asked to turn head&#xD;
           to respond to physician request (e.g. sign paper, count fingers, answer question).&#xD;
&#xD;
        4. Regional disturbances&#xD;
&#xD;
             1. Sensory disturbances that deviate from normal neuroanatomy or pathology (e.g.&#xD;
                single herniated disc causing pain throughout entire arm or radiating into lower&#xD;
                back)&#xD;
&#xD;
             2. Motor disturbances that deviate from normal neuroanatomy or pathology (e.g.&#xD;
                dramatic non-neurological weakness, give-away weakness)&#xD;
&#xD;
        5. Overreaction&#xD;
&#xD;
             1. Verbal (e.g. crying, screaming)&#xD;
&#xD;
             2. Non-verbal (e.g. exaggerated grimacing, clutching affected area, abnormally slow or&#xD;
                rigid movements)&#xD;
&#xD;
      The investigators will evaluate MRI results to determine the precise pathology. Patients will&#xD;
      then receive interlaminar cervical ESI. In accordance with standard practice, a Tuohy needle&#xD;
      will be directed towards the side of the radicular pain, with correct needle position in the&#xD;
      epidural space being confirmed with real-time contrast injection. Once the physician is&#xD;
      satisfied with the spread, a 3 mL solution consisting of depo-methylprednisolone 40 mg + 2 mL&#xD;
      normal saline will be injected. At Seoul National University, due to Korean healthcare&#xD;
      regulations, the mixture will be a 3 mL solution containing 10 mg of dexamethasone and 2 mL&#xD;
      saline. The primary outcome measure will be the difference in the proportion of people with a&#xD;
      positive categorical outcome, defined as a &gt;/= 2-point decrease in average arm pain 4 weeks&#xD;
      post-procedure coupled with a score &gt;/= 5 on a 7-point patient global impression of change&#xD;
      (PGIC) scale 4 weeks post-treatment, indicating subjective improvement. Secondary outcome&#xD;
      measures will include mean reductions in average and worst 0-10 numerical rating scale (NRS)&#xD;
      arm pain scores over the past 7 days, mean reduction in average and worst neck pain scores,&#xD;
      neck disability index (NDI) score, medication usage, patient global impression of change&#xD;
      (PGIC), Hospital Anxiety and Depression Scale (HADS), Athens Insomnia Scale (AIS), Somatic&#xD;
      Symptom Scale-8 (SSS-8), and side effects. Individuals who experience a positive categorical&#xD;
      outcome at 4 weeks will continue to be evaluated at 12 weeks, while those with a negative&#xD;
      outcome will exit the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Categorical response</measure>
    <time_frame>4 weeks</time_frame>
    <description>Positive response is defined as a &gt;/= 2-point reduction in average arm pain coupled with &gt;/= 5/7 score on patient global impression of change. Anything else is a negative response.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average arm pain</measure>
    <time_frame>4 weeks</time_frame>
    <description>Average arm pain on 0-10 numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worst arm pain</measure>
    <time_frame>4 weeks</time_frame>
    <description>Worst arm pain on 0-10 numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average neck pain</measure>
    <time_frame>4 weeks</time_frame>
    <description>Average neck pain on 0-10 numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worst neck pain</measure>
    <time_frame>4 weeks</time_frame>
    <description>Worst neck pain on 0-10 numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neck disability index (NDI) score</measure>
    <time_frame>4 weeks</time_frame>
    <description>NDI Score on 0-10 numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Somatic Symptom Scale (SS-8) score</measure>
    <time_frame>4 weeks</time_frame>
    <description>8-question survey, out of 32 points measuring somatization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Athens Insomnia Scale (AIS) score</measure>
    <time_frame>4 weeks</time_frame>
    <description>8-question survey, out of 24 points measuring sleep quality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>4 weeks</time_frame>
    <description>14-question survey measuring anxiety and depression (each out of 21 points).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change (PGIC) scale</measure>
    <time_frame>4 weeks</time_frame>
    <description>7-point Likert scale measuring patient-reported improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Impression of Change (PGIC) scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>7-point Likert scale measuring patient-reported improvement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>12 weeks</time_frame>
    <description>14-question survey measuring anxiety and depression (each out of 21 points).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Athens Insomnia Scale (AIS) score</measure>
    <time_frame>12 weeks</time_frame>
    <description>8-question survey, out of 24 points measuring sleep quality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Somatic Symptom Scale (SS-8) score</measure>
    <time_frame>12 weeks</time_frame>
    <description>8-question survey, out of 32 points measuring somatization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average arm pain</measure>
    <time_frame>12 weeks</time_frame>
    <description>Average arm pain on 0-10 numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worst arm pain</measure>
    <time_frame>12 weeks</time_frame>
    <description>Worst arm pain on 0-10 numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average neck pain</measure>
    <time_frame>12 weeks</time_frame>
    <description>Average neck pain on 0-10 numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worst neck pain</measure>
    <time_frame>12 weeks</time_frame>
    <description>Worst neck pain on 0-10 numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neck disability index (NDI) score</measure>
    <time_frame>12 weeks</time_frame>
    <description>NDI Score on 0-10 numerical rating scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Categorical response</measure>
    <time_frame>12 weeks</time_frame>
    <description>Positive response is a &gt;/= 2-point reduction in average arm pain coupled with &gt;/= 5/7 score on patient. Anything else is a negative response.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Cervical Radiculopathy</condition>
  <condition>Cervical Radicular Pain</condition>
  <arm_group>
    <arm_group_label>Cervical epidural steroid injection</arm_group_label>
    <description>This group will receive an interlaminar cervical ESI at C6-7 or C7-T1 with 1 mL steroid (depo-methylprednisolone 40 mg at Johns Hopkins and the DC VA Hospital or dexamethasone 10 mg at Seoul National University) and 2 mL normal saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cervical epidural steroid injection</intervention_name>
    <description>Interlaminar cervical epidural steroid injection with steroid and normal saline at C6-7 and C7-T1 (standard of care).</description>
    <arm_group_label>Cervical epidural steroid injection</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with clinical and MRI evidence of cervical radicular pain who are scheduled&#xD;
        to undergo cervical epidural steroid injection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18&#xD;
&#xD;
          -  Cervical radicular pain based on history and physical exam (e.g. pain radiating into&#xD;
             one or both extremities, sensory loss, muscle weakness, Spurling's test etc.)&#xD;
&#xD;
          -  Pain duration &gt; 6 weeks&#xD;
&#xD;
          -  Average NRS arm pain score &gt; 4&#xD;
&#xD;
          -  MRI evidence of disc pathology consistent with symptoms&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Untreated coagulopathy&#xD;
&#xD;
          -  Previous spine surgery&#xD;
&#xD;
          -  No MRI study&#xD;
&#xD;
          -  Epidural steroid injection within past 3 years&#xD;
&#xD;
          -  Radiculopathy resulting from tumor or herpes zoster&#xD;
&#xD;
          -  Signs or symptoms or myelopathy or spinal cord compression&#xD;
&#xD;
          -  Allergic reactions to contrast allergy including macrocyclic gadolinium or&#xD;
             depo-methylprednisolone&#xD;
&#xD;
          -  Referrals from surgery for diagnostic injections for surgical evaluation&#xD;
&#xD;
          -  Serious medical (e.g. congestive heart failure) condition that might preclude optimal&#xD;
             outcome&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Steven P Cohen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steven P Cohen, MD</last_name>
    <phone>4109551822</phone>
    <email>scohen40@jhmi.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Grace Crawford, BA</last_name>
    <phone>4109551822</phone>
    <email>gcrawfo7@jhu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>DC VA Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20422</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steve P Cohen, MD</last_name>
      <phone>410-955-1822</phone>
      <email>scohen40@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seoul National University</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jee Youn Moon, MD, PhD</last_name>
      <phone>82-2-2072-0505</phone>
      <email>jymoon0901@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Fishbain DA, Cole B, Cutler RB, Lewis J, Rosomoff HL, Rosomoff RS. A structured evidence-based review on the meaning of nonorganic physical signs: Waddell signs. Pain Med. 2003 Jun;4(2):141-81. Review.</citation>
    <PMID>12911018</PMID>
  </reference>
  <reference>
    <citation>Waddell G, McCulloch JA, Kummel E, Venner RM. Nonorganic physical signs in low-back pain. Spine (Phila Pa 1976). 1980 Mar-Apr;5(2):117-25.</citation>
    <PMID>6446157</PMID>
  </reference>
  <reference>
    <citation>Jorritsma W, Dijkstra PU, De Vries GE, Geertzen JH, Reneman MF. Physical dysfunction and nonorganic signs in patients with chronic neck pain: exploratory study into interobserver reliability and construct validity. J Orthop Sports Phys Ther. 2014 May;44(5):366-76. doi: 10.2519/jospt.2014.4715. Epub 2014 Apr 14.</citation>
    <PMID>24730436</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cervicalgia</keyword>
  <keyword>Neck pain</keyword>
  <keyword>Cervical radiculopathy</keyword>
  <keyword>Cervical radicular pain</keyword>
  <keyword>Epidural steroid injection</keyword>
  <keyword>Non-organic sign</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiculopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Upon request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Up to 3 years after publication</ipd_time_frame>
    <ipd_access_criteria>Upon request, contingent on objectives</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

